Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors.
about
Perioperative corticosteroids for reducing postoperative complications following esophagectomyImmune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infectionThe Role of Steroid Hormones in the Modulation of Neuroinflammation by Dietary InterventionsOne hormone, two actions: anti- and pro-inflammatory effects of glucocorticoidsIdentification of glucocorticoid receptor domains involved in transrepression of transforming growth factor-beta actionThe characteristic long-term upregulation of hippocampal NF-κB complex in PTSD-like behavioral stress response is normalized by high-dose corticosterone and pyrrolidine dithiocarbamate administered immediately after exposure.Dexamethasone restrains ongoing expression of interleukin-23p19 in peripheral blood-derived human macrophages.Neuroendocrine-immune interactions in rheumatoid arthritis: mechanisms of glucocorticoid resistance.Polymorphisms in the 3'-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression.c-Myb and members of the c-Ets family of transcription factors act as molecular switches to mediate opposite steroid regulation of the human glucocorticoid receptor 1A promoter.Incidence and risk factors of steroid-induced diabetes in patients with respiratory diseaseDefensin expression by the cornea: multiple signalling pathways mediate IL-1beta stimulation of hBD-2 expression by human corneal epithelial cellsLiposome-encapsulated prednisolone phosphate inhibits growth of established tumors in mice.Glucocorticoid-independent repression of tumor necrosis factor (TNF) alpha-stimulated interleukin (IL)-6 expression by the glucocorticoid receptor: a potential mechanism for protection against an excessive inflammatory response.Targeting Nuclear Hormone Receptors: PPARα Agonists as Potential Disease-Modifying Drugs for Rheumatoid Arthritis.The hypothalamic-pituitary-adrenal axis and low-dose glucocorticoids in the treatment of septic shock.Type I interferon and systemic lupus erythematosus.Experience with experimental biological treatment and local gene therapy in Sjogren's syndrome: implications for exocrine pathogenesis and treatment.Effect of corticosteroids and neuropeptides on the expression of defensins in bovine tracheal epithelial cells.Dexamethasone-eluting stent: an anti-inflammatory approach to inhibit coronary restenosis.The Impact of Intramammary Escherichia coli Challenge on Liver and Mammary Transcriptome and Cross-Talk in Dairy Cows during Early Lactation Using RNAseq.Age-related neuroinflammation and changes in AKT-GSK-3β and WNT/ β-CATENIN signaling in rat hippocampus.Hydrocortisone-induced anti-inflammatory effects in immature human enterocytes depend on the timing of exposure.Targeting NF-kappaB: a promising molecular therapy in inflammatory arthritis.Glucocorticoids exacerbate lipopolysaccharide-induced signaling in the frontal cortex and hippocampus in a dose-dependent manner.Repression of DNA-binding dependent glucocorticoid receptor-mediated gene expressionREV-ERBα influences the stability and nuclear localization of the glucocorticoid receptor.Glucocorticoids inhibit the innate immune system of human corneal fibroblast through their suppression of toll-like receptorsCurrent and future treatments of autoimmune hepatitis.Hepatic inflammation and progressive liver fibrosis in chronic liver disease.Regulation of drug-metabolizing cytochrome P450 enzymes by glucocorticoids.Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation.Drug choices in autoimmune hepatitis: part A--Steroids.Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis.Tethering not required: the glucocorticoid receptor binds directly to activator protein-1 recognition motifs to repress inflammatory genes.Compound A influences gene regulation of the Dexamethasone-activated glucocorticoid receptor by alternative cofactor recruitment.Evolving paradigm of treatment for autoimmune hepatitis.Structural Analysis of the Glucocorticoid Receptor Ligand-Binding Domain in Complex with Triamcinolone Acetonide and a Fragment of the Atypical Coregulator, Small Heterodimer Partner.Targeting Hepatic Fibrosis in Autoimmune Hepatitis.Microglia Priming with Aging and Stress.
P2860
Q24188218-65499016-B69D-4BB4-91F9-C2500723C0F1Q24531350-5240ECE8-EA1D-43FB-ADA1-02929AA982F7Q26766454-9D22BB8A-EAFF-42A8-81FE-FF82AA6F31F7Q26830948-DB6FCF13-B22D-4522-9751-5CE2C3FA32A2Q28155857-E447C65F-642D-4CA2-B27B-8BA7BD8AEA45Q30463127-AFB6FDBD-907A-4C6F-A435-18973B6AE434Q33972053-B281F319-D8A6-41E3-B817-CF37F137A130Q34060256-F69C8C8B-7734-426F-B6D0-EEB7EFED9BE0Q34110468-98C95181-A15E-4A9A-9DD4-86B25E41E6F1Q34464525-9BDB5911-CBE5-4F90-A2D8-9A55C53D5250Q34539990-AA9CBCAE-857D-4CE5-86D1-DD2EC5785466Q34758069-838AE8C1-1E1D-4DFC-86E5-5E73D4A88969Q34768310-E607E405-022B-4F97-82D2-45918B9CC244Q35010893-3786E78A-F70D-4A6F-9180-9EB20E6D3082Q35098905-6267C594-DCC1-496C-9C3E-E33C259D8FB3Q35101483-FA91D429-800D-4F47-9687-ADE40BA06F9AQ35549980-B4D22AD3-2163-4D60-8D58-A72D9B52730BQ35638200-3CC3239D-4D41-41D0-B67C-E337C604BC7EQ35689485-DC26445D-6F82-40E8-A302-EF17D4B9FD66Q35879059-02B09C18-AA29-43E8-ADCF-137C9D9DC4DAQ36060054-6810C300-9F30-4AA2-9AA5-AE5EAA7A09A0Q36460797-8214B44C-E964-4DEF-AF03-558F716E14F0Q37071775-ADD8B6BC-7A2C-4FB5-8357-CC32A92D5272Q37293344-C61813BA-D5C4-47C8-ABAE-0A90DE0B79F5Q37347677-D4206B2E-1F40-4BB9-B3CA-5382EFC847C4Q37348402-3E016EF1-6921-4B11-805A-35E82F0398DAQ37425929-F8BB7B25-B004-4191-ADF1-3D93EEFC4887Q37452598-1023E9B9-B710-4451-B5B5-36B905F51B45Q37503380-BF16D925-6259-4488-8948-9052ED5C6074Q37629675-F011F606-0A71-4754-B26B-11EBDECB174DQ37756178-A12A3D03-68AB-4114-9888-867D3F4FE86BQ38007886-3FB285F2-59C3-48EB-8FD5-29C3E9D70304Q38051705-4630D918-569E-4E23-B8C3-7EA0B790CBD4Q38348120-EB898E0A-23EB-4629-BEA0-06295573112BQ38430684-A738E19F-09D5-470B-AB5D-680C2176AA27Q38642503-EA56B8C2-09F7-4A0E-BD7E-B47475926290Q38730872-B5FBD4C3-0F11-4AD9-892D-A62C0D7D6732Q38843487-7F1A7367-B667-4B07-9058-346320725B12Q38902371-0C873798-4D5D-4F01-8117-842EAB8F9BFEQ38948754-1EEE93B5-7238-4607-AC48-37C12AC2A4E9
P2860
Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Mechanisms of anti-inflammator ...... or with transcription factors.
@ast
Mechanisms of anti-inflammator ...... or with transcription factors.
@en
Mechanisms of anti-inflammator ...... or with transcription factors.
@nl
type
label
Mechanisms of anti-inflammator ...... or with transcription factors.
@ast
Mechanisms of anti-inflammator ...... or with transcription factors.
@en
Mechanisms of anti-inflammator ...... or with transcription factors.
@nl
prefLabel
Mechanisms of anti-inflammator ...... or with transcription factors.
@ast
Mechanisms of anti-inflammator ...... or with transcription factors.
@en
Mechanisms of anti-inflammator ...... or with transcription factors.
@nl
P2093
P1476
Mechanisms of anti-inflammator ...... or with transcription factors.
@en
P2093
G Haegeman
K De Bosscher
W Vanden Berghe
P356
10.1016/S0165-5728(00)00297-6
P577
2000-09-01T00:00:00Z